Seroprevalence of HIV antibody among individuals entering the Iowa Prison System. 1988

G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
Iowa Medical and Classification Center, Iowa Department of Corrections, Oakdale 52319.

From January 1 to April 30, 1986, all individuals entering the Iowa prison system were tested for antibody to the human immunodeficiency virus (HIV). Sera were collected on 363 newly incarcerated inmates, 389 inmates returning to prison, and 107 forensic psychiatric patients. Three of the 859 serum samples (0.3 per cent) tested during this study were reactive by ELISA (enzyme-linked immunosorbent assay) testing, but none reactive by the Western blot. Analysis for AIDS risk factors included a high prior IV-drug use rate (22-50 per cent) and a low admitted homosexuality rate in a predominantly young white male population.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D007484 Iowa State bounded on the north by Minnesota, on the east by Wisconsin and Illinois, on the south by Missouri, and on the west by Nebraska and South Dakota.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011329 Prisoners Persons deprived of their liberty; those held is against their will, or who are kept in confinement or custody. Detained Persons,Hostages,Imprisoned Individuals,Incarcerated Individuals,Inmates,Detained Person,Hostage,Imprisoned Individual,Incarcerated Individual,Individual, Imprisoned,Individual, Incarcerated,Inmate,Person, Detained,Prisoner
D011330 Prisons Penal institutions, or places of long-term confinement for prisoners. Penitentiaries,Penitentiary,Prison
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
October 1990, The Western journal of medicine,
G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
May 1998, WMJ : official publication of the State Medical Society of Wisconsin,
G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
January 2008, The journal of the American Academy of Psychiatry and the Law,
G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
January 1992, Journal of acquired immune deficiency syndromes,
G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
November 2012, Sexually transmitted infections,
G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
September 1990, American journal of public health,
G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
April 2009, Revista panamericana de salud publica = Pan American journal of public health,
G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
January 1989, Journal of acquired immune deficiency syndromes,
G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
January 1990, Public health reports (Washington, D.C. : 1974),
G E Glass, and W J Hausler, and P L Loeffelholz, and C E Yesalis
May 1991, American journal of public health,
Copied contents to your clipboard!